Samrat Pharmachem informs about credit rating

03 Jun 2025 Evaluate
Samrat Pharmachem has informed that Crisil Limited has upgraded its rating on the bank facilities to ‘Crisil BBB- /Stable/Crisil A3’ from 'Crisil BB+/Stable/Crisil A4+. Details enclosed.

The above information is a part of company’s filings submitted to BSE.

Samrat Pharmachem Share Price

211.90 1.55 (0.74%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×